Farnia et al Dovepress 29.Elnazer HY,Baldwin DS.Treatment with citalopram,but not with 52.Chevallier A.The Encyclopedia of Medicinal Plants.London:Dorling agomelatine,adversely affects sperm parameters:a case report and Kindersely;1996 translational review.Acta Neuropsychiatr.2014:26(2):125-129. 53.Rusanov K,Kovacheva N.Vosman B,et al.Microsatellite analysis of 30.Segraves RT.Effects of psychotropic drugs on human erection and Rosa damascena Mill.accessions reveals genetic similarity between ejaculation.Arch Gen Psychiatry.1989;46(3):275-284. genotypes used for rose oil production and old Damask rose varieties 31.Clayton AH,ZajeckaJ,Ferguson JM,Filipiak-Reisner JK,Brown MT, Theor Appl Genet..2005;111(4):804-809. Schwartz GE.Lack of sexual dysfunction with the selective noradrena- 54.Tabaei-Aghdaei SR,Babaei A,Khosh-Khui M,et al.Morphological line reuptake inhibitor reboxetine during treatment for major depressive and oil content variations amongst Damask rose (Rosa damascena disorder.Int Clin Psychopharmacol.2003:18(3):151-156. Mill.)landraces from different regions of Iran.Sci Hortic.2007:113: 32.Kanaly KA,Berman JR.Sexual side effects of SSRI medications: 44-48. potential treatment strategies for SSRI-induced female sexual dysfunc- 55.Basim E.Basim H.Antibacterial activity of Rosa damascena essential tion.Curr Womens Health Rep.2002:2(6):409-416 oil.Fitoterapia.2003:74(4):394-396. 33.Keltner NL,McAfee KM,Taylor CL.Mechanisms and treat- 56.Shokouhinejad N,Emaneini M,Aligholi M,Jabalameli F.Antimicrobial ments of SSRI-induced sexual dysfunction.Persp Psychiatr Care effect of Rosa damascena oil on selected endodontic pathogens.Journal 2002:383:111-116. of the California Dental Association.2010:38(2):123-126. 34.Montejo AL,Llorca G.Izquierdo JA,Rico-Villademoros F.Incidence 57.Awale S,Tohda C,Tezuka Y,Miyazaki M,Kadota S.Protective effects of sexual dysfunction associated with antidepressant agents:a prospec- of rosa damascena and its active constituent on AB(25-35)-induced tive multicenter study of 1022 outpatients.J Clin Psychiatry.2001:62: neuritic atrophy.Evid Based Complement Alternat Med.2011:149: 10-21. 131042. 35.Balon R.SSRI-Associated Sexual Dysfunction.Am J Psychiatry. 58.Ramezani R.Moghimi A.Rakhshandeh H,Eitehadi H.Kheirabadi M. 2006:163(9:1504-1509. The effect of Rosa damascena essential oil on the amygdala electrical 36.Kennedy SH.Rizvi S.Sexual dysfunction.depression.and the impact kindling seizures in rat.Pak J Biol Sci.2008:11(5):746-751 of anti-depressants.J Clin Psychopharmacol.2009;29(2):157-164. 59.Loghmani-Khouzani H,Sabzi Fini O,Safari J.Essential oil composi- 37.BullSA.Hunkeler EM,Lee JY.Discontinuing or switching selective sero- tion of Rosa damascena mill cultivated in central Iran.Scientia /ranica. tonin-reuptake inhibitors.Ann Pharmacother.2002:36(4):578-584. 2007:144:316-319. 38.Hu XH.Bull SA,Hunkeler EM,et al.Incidence and duration of side 60.Kumar N.Bhandari P,Singh B,Gupta AP,Kaul VK.Reversed phase- effects and those rated as bothersome with selective serotonin reuptake HPLC for rapid determination ofpolyphenols in flowers of rose species. inhibitor treatment for depression:patient report versus physician J Sep Sci.2008:31(2):262-267. estimate.J Clin Psychiatry.2004;65(7):959-965. 61.Sheehan DV,Lecrubier Y.Sheehan KH.et al.The Mini-International 39.Maund E,Tendal B,Hrobjartsson A.et al.Benefits and harms in Neuropsychiatric Interview (M.I.N.I.):the development and valida- clinical trials of duloxetine for treatment of major depressive disorder. tion of a structured diagnostic psychiatric interview for DSM-IV and comparison of clinical study reports,trial registries,and publications ICD-10.JClin Psychiatry.1998:59(Suppl 20):22-33. BMU.2014:348:g3510. 62.American Psychiatric Association.The Diagnostic and Statistical 40.Nurnberg HG.An evidence-based review updating the various treatment Manual of Mental Disorders.5th ed.Arlington:American Psychiatric and management approaches to serotonin reuptake inhibitor-associated Publishing:2013. sexual dysfunction.Drugs Today(Barc.以2008；44(2：147-168. 63.Mykletun A,Dahl AA,O'Leary MP,Fossa SD.Assessment of male 41.Sela Y.Shackelford TK,Pham MN,Euler HA.Do women perform sexual function by the Brief Sexual Function Inventory.B./U Int.2006; fellatio as a mate retention behavior?Pers Individ Diffs.2015:73 97(2):316-323. 61-66. 64.Beck AT.Beck depression inventory.Philadelphia:Center for Cognitive 42.Buss D.Evolutionary Psychology:The New Science of Mind.Essex: Therapy:1961. Pearson:2013. 65.Xu SL,Zhu KY,Bi CW.et al.Flavonoids induce the expression 43.Diamond J.The Third Chimpanzee:The Evolution and Future of the of synaptic proteins,synaptotagmin,and postsynaptic density Human Animal.New York:HarperCollins Publisher:1992. protein-95 in cultured rat cortical neuron.Planta Med.2013:79(18): 44.Meston CM.Buss DM.Why Women Have Sex:Understanding Sexual 1710-1714 Motivations from Adventure to Revenge (and Everything in Between). 66.ChakrabortyJ.Singh R,DuttaD.NaskarA.RajammaU.Mohanakumar KP. New York:Henry Holt and Company:2009. Quercetin improves behavioral deficiencies,restores astrocytes and 45.Miller G.The Mating Mind:How Sexual Choice Shaped the Evolution microglia,and reduces serotonin metabolism in 3-nitropropionic of Human Nature.New York:Random House;2000. acid-induced rat model of Huntington's disease.CNS Neurosci Ther. 46.Damis M,Patel Y,Simpson GM.Sildenafil in the treatment of SSRI- 2014:20(1:10-19. induced sexual dysfunction:a pilot study.Prim Care Companion./Clin 67.Merzoug S,Toumi ML,Tahraoui A.Quercetin mitigates Adriamycin- Psychiatry.1999:1(6:184-187. induced anxiety-and depression-like behaviors,immune dysfunction, 47.Taylor MJ.Rudkin L,Bullemor-Day P.Lubin J,Chukwujekwu C. and brain oxidative stress in rats.Naunyn Schmiedebergs Arch Phar- Hawton K.Strategies for managing sexual dysfunction induced by macol.2014:387(10):921-933. antidepressant medication.Cochrane Database Syst Rev.2013:5: 68.Hou Y.Aboukhatwa MA.Lei DL,Manaye K.Khan I.Luo Y.Anti- CD003382. depressant natural flavonols modulate BDNF and beta amyloid in 48.Dolberg OT,Klag E,Gross Y,Schreiber S.Relief of serotonin selec- neurons and hippocampus of double TgAD mice.Neuropharmacology. tive reuptake inhibitor induced sexual dysfunction with low-dose 2010:58(6:911-920. mianserin in patients with traumatic brain injury.Psychopharmacology. 69.Mikoteit T,Beck J,Eckert A,et al.High baseline BDNF serum levels 2002:161(4):404-407. and early psychopathological improvement are predictive of treatment 49.DeBattista C.Solvason B.Poirier J,Kendrick E.Loraas E.A placebo- outcome in major depression./Psychopharmacol (Berl).2014:231(15): controlled,randomized,double-blind study of adjunctive bupropion 2955-2965. sustained release in the treatment of SSRI-induced sexual dysfunction. 70.Giese M.Beck J.Brand S et al.Fast BDNF serum level increase and J Clin Psychiatry.2005:66(7):844-848. diurnal BDNF oscillations are associated with therapeutic response 50.Segraves RT,Balon R.Sexual Pharmacology:Fast Facts.New York: after partial sleep deprivation.Psychiatr Res.2014:59:1-7. WW Norton and Company;2003. 71.Irwin SA,Iglewicz A.Oral ketamine for the rapid treatment of depres 51.Boskabady MH.Shafei MN,SaberiZ,Amini S.Pharmacological effects sion and anxiety in patients receiving hospice care./Palliat Med.2010: of rosa damascena.Iran J Basic Med Sci.2011:14(4):295-307. 13(7):903-908 634 submit your manuscrpe Neuropsychiatric Disease and Treatment 2015:I I DovepressNeuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com Dovepress Dovepress 634 Farnia et al 29. Elnazer HY, Baldwin DS. Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: a case report and translational review. Acta Neuropsychiatr. 2014;26(2):125–129. 30. Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry. 1989;46(3):275–284. 31. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lack of sexual dysfunction with the selective noradrena￾line reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol. 2003;18(3):151–156. 32. Kanaly KA, Berman JR. Sexual side effects of SSRI medications: potential treatment strategies for SSRI-induced female sexual dysfunc￾tion. Curr Womens Health Rep. 2002;2(6):409–416. 33. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treat￾ments of SSRI-induced sexual dysfunction. Persp Psychiatr Care. 2002;38(3):111–116. 34. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospec￾tive multicenter study of 1022 outpatients. J Clin Psychiatry. 2001;62: 10–21. 35. Balon R. SSRI-Associated Sexual Dysfunction. Am J Psychiatry. 2006;163(9):1504–1509. 36. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of anti-depressants. J Clin Psychopharmacol. 2009;29(2):157–164. 37. Bull SA, Hunkeler EM, Lee JY. Discontinuing or switching selective sero￾tonin-reuptake inhibitors. Ann Pharmacother. 2002;36(4):578–584. 38. Hu XH, Bull SA, Hunkeler EM, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry. 2004;65(7):959–965. 39. Maund E, Tendal B, Hróbjartsson A, et al. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. BMJ. 2014;348:g3510. 40. Nurnberg HG. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today (Barc). 2008;44(2):147–168. 41. Sela Y, Shackelford TK, Pham MN, Euler HA. Do women perform fellatio as a mate retention behavior? Pers Individ Diffs. 2015;73: 61–66. 42. Buss D. Evolutionary Psychology: The New Science of Mind. Essex: Pearson; 2013. 43. Diamond J. The Third Chimpanzee: The Evolution and Future of the Human Animal. New York: HarperCollins Publisher; 1992. 44. Meston CM, Buss DM. Why Women Have Sex: Understanding Sexual Motivations from Adventure to Revenge (and Everything in Between). New York: Henry Holt and Company; 2009. 45. Miller G. The Mating Mind: How Sexual Choice Shaped the Evolution of Human Nature. New York: Random House; 2000. 46. Damis M, Patel Y, Simpson GM. Sildenafil in the treatment of SSRI￾induced sexual dysfunction: a pilot study. Prim Care Companion J Clin Psychiatry. 1999;1(6):184–187. 47. Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev. 2013;5: CD003382. 48. Dolberg OT, Klag E, Gross Y, Schreiber S. Relief of serotonin selec￾tive reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. Psychopharmacology. 2002;161(4):404–407. 49. DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo￾controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66(7):844–848. 50. Segraves RT, Balon R. Sexual Pharmacology: Fast Facts. New York: WW Norton and Company; 2003. 51. Boskabady MH, Shafei MN, Saberi Z, Amini S. Pharmacological effects of rosa damascena. Iran J Basic Med Sci. 2011;14(4):295–307. 52. Chevallier A. The Encyclopedia of Medicinal Plants. London: Dorling Kindersely; 1996. 53. Rusanov K, Kovacheva N, Vosman B, et al. Microsatellite analysis of Rosa damascena Mill. accessions reveals genetic similarity between genotypes used for rose oil production and old Damask rose varieties. Theor Appl Genet. 2005;111(4):804–809. 54. Tabaei-Aghdaei SR, Babaei A, Khosh-Khui M, et al. Morphological and oil content variations amongst Damask rose (Rosa damascena Mill.) landraces from different regions of Iran. Sci Hortic. 2007;113: 44–48. 55. Basim E, Basim H. Antibacterial activity of Rosa damascena essential oil. Fitoterapia. 2003;74(4):394–396. 56. Shokouhinejad N, Emaneini M, Aligholi M, Jabalameli F. Antimicrobial effect of Rosa damascena oil on selected endodontic pathogens. Journal of the California Dental Association. 2010;38(2):123–126. 57. Awale S, Tohda C, Tezuka Y, Miyazaki M, Kadota S. Protective effects of rosa damascena and its active constituent on Aß(25–35)-induced neuritic atrophy. Evid Based Complement Alternat Med. 2011;149: 131042. 58. Ramezani R, Moghimi A, Rakhshandeh H, Ejtehadi H, Kheirabadi M. The effect of Rosa damascena essential oil on the amygdala electrical kindling seizures in rat. Pak J Biol Sci. 2008;11(5):746–751. 59. Loghmani-Khouzani H, Sabzi Fini O, Safari J. Essential oil composi￾tion of Rosa damascena mill cultivated in central Iran. Scientia Iranica. 2007;14(4):316–319. 60. Kumar N, Bhandari P, Singh B, Gupta AP, Kaul VK. Reversed phase￾HPLC for rapid determination of polyphenols in flowers of rose species. J Sep Sci. 2008;31(2):262–267. 61. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and valida￾tion of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33. 62. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013. 63. Mykletun A, Dahl AA, O’Leary MP, Fosså SD. Assessment of male sexual function by the Brief Sexual Function Inventory. BJU Int. 2006; 97(2):316–323. 64. Beck AT. Beck depression inventory. Philadelphia: Center for Cognitive Therapy; 1961. 65. Xu SL, Zhu KY, Bi CW, et al. Flavonoids induce the expression of synaptic proteins, synaptotagmin, and postsynaptic density protein-95 in cultured rat cortical neuron. Planta Med. 2013;79(18): 1710–1714. 66. Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington’s disease. CNS Neurosci Ther. 2014;20(1):10–19. 67. Merzoug S, Toumi ML, Tahraoui A. Quercetin mitigates Adriamycin￾induced anxiety- and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats. Naunyn Schmiedebergs Arch Phar￾macol. 2014;387(10):921–933. 68. Hou Y, Aboukhatwa MA, Lei DL, Manaye K, Khan I, Luo Y. Anti￾depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology. 2010;58(6):911–920. 69. Mikoteit T, Beck J, Eckert A, et al. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression. J Psychopharmacol (Berl). 2014;231(15): 2955–2965. 70. Giese M, Beck J, Brand S et al. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. J Psychiatr Res. 2014; 59:1–7. 71. Irwin SA, Iglewicz A. Oral ketamine for the rapid treatment of depres￾sion and anxiety in patients receiving hospice care. J Palliat Med. 2010; 13(7):903–908